Regenxbio and UPenn Lose Legal Battle Over Muscular Dystrophy Treatment Patent to Sarepta

Published on :

Regenxbio and UPenn Lose Legal Battle Over Muscular Dystrophy Treatment Patent to Sarepta Published on January 6, 2024 In a major legal showdown over patents and innovation, Sarepta Therapeutics (SRPT.O) [….]

Weekly Quick Hits (Greater Philly) – Week of May 29, 2023

Published on :

Weekly Quick Hits (Greater Philly) – Week of May 29, 2023 By Mark TerryJune 2, 2023 Funding, Awards and Collaborations CHOP and More than 20 Institutions Create Open-Analysis Platform for [….]

Weekly Quick Hits (Greater Philly) – Week of May 8, 2023

Published on :

Weekly Quick Hits (Greater Philly) – Week of May 8, 2023 By Mark TerryMay 12, 2023 Funding, Awards and Collaborations Interius Announces Manufacturing Partnership with WuXi Advanced Therapies Philadelphia-based Interius [….]

Weekly Quick Hits (Greater Philly) – Week of April 17, 2023

Published on :

Weekly Quick Hits (Greater Philly) – Week of April 17, 2023 By Mark Terry, Alex Keown, and Sarah EllinwoodApril 21, 2023 Funding, Awards and Collaborations TELA Bio Announces Pricing of [….]

Penn and Michael J. Fox Foundation ID Breakthrough Biomarker in Parkinson’s Disease

Published on :

Penn and Michael J. Fox Foundation ID Breakthrough Biomarker in Parkinson’s Disease By Mark TerryApril 17, 2023 Researchers with the University of Pennsylvania Perelman School of Medicine and others, with [….]

Weekly Quick Hits (Greater Philadelphia) – Week of January 23, 2023

Published on :

Here’s what’s been happening Greater Philadelphia’s Life Science scene the week of January 23, 2023

Athletes and Scientists Partner to Support Rare Disease Research

Published on :

Sponsored by the not-for-profit Uplifting Athletes, the Young Investigators Draft provides $20,000 grants to 10 beginning-career stage research scientists in the rare disease community. The award is an unrestricted grant that will support the vital investigation of potential therapies and cures, including gene therapies, for rare disease, said Rob Long, executive director of Uplifting Athletes.

Greater Philadelphia Q4 2022 News Recap – December was a Pivotal Month for Cellicon Valley Companies

Published on :

Cellicon Valley companies closed out 2022 with a roar. Madrigal Pharmaceuticals announced a breakthrough in NASH that could result in the first-approved drug for that disease. Galera Therapeutics closed out December with plans to seek approval for its severe oral mucositis therapy.

Universal mRNA flu vaccine out of Univ. of Pennsylvania may be available within two years, says scientist

Published on :

Universal flu vaccine may be available within two years, says scientist
Vaccine against all strains of virus hailed as major step in protecting against potentially devastating flu pandemic
The new vaccine is designed to prime the immune system against all 20 subtypes of influenza A and B, potentially arming the body to tackle any flu virus that arises. Photograph: Peter Byrne/PA
Ian Sample Science editor
@iansample
Fri 25 Nov 2022 06.05 EST
A universal flu vaccine that protects against all strains of the virus could be available in the next two years, according to a leading scientist.
An experimental vaccine based on the same mRNA technology used in the highly successful Covid jabs was found to protect mice and ferrets against severe influenza, paving the way for clinical trials in humans.
Prof John Oxford, a virologist at Queen Mary University in London, who was not involved in the work, said the vaccine developed at the University of Pennsylvania could be ready for use the winter after next.
“I cannot emphasise enough what a breakthrough this paper is,” Oxford told the BBC’s Radio 4 Today programme. “The potential is huge, and I think sometimes we underestimate these big respiratory viruses.”
Advertisement…